Pleicomacrolides, a class of antibiotics, may help immune system kill HIV-infected cells, shows study
When the researchers used Concanamycin A to treat HIV-infected Nef-expressing cells, they found that it activated a particular type of immune cells, which then cleared off the HIV-infected cells
As per a report by the Joint United Nations Programme on HIV/AIDS by the United Nations in 2018, around 37.9 million people are living with Human Immunodeficiency Virus (HIV) across the globe. HIV is a virus that attacks the body’s immune system, making it prone to various other infections. It spreads through fluid exchange (blood, semen and vaginal secretions) between a healthy person and a person with HIV. Currently, there is no cure for HIV. However, a study published in the journal Proceedings of the National Academy of Sciences showed that a certain kind of antibiotic can prove effective in stimulating the immune system to clear the HIV infected cells by inhibiting a protein called Nef.
The Nef protein
It was already established in 1998 that HIV uses Nef to confuse the body's immune system and overrides a protein called major histocompatibility class I (MHC-I), present on the surface of the cell, which otherwise tells the immune cells that a particular cell is infected and needs to be discarded soon. Nef is an HIV-encoded accessory protein which increases the infective ability of the virus by suppressing MHC-I. Once MHC-I is disabled, the infected cells keep on proliferating, thereby spreading the infection.
In order to prevent the spread of infection, scientists needed to find a potent Nef inhibitor which restores the activity of MHC-I.
Destroying HIV-infected cells
Initially, scientists from the University of Michigan examined different FDA-approved drugs or molecules that were already present in the market. The drug needs to be effective enough to override or restrict Nef, restore the functioning ability of MHC-I and allow the immune system, especially the cytotoxic T lymphocytes, to recognise the HIV-infected cells on their own and destroy them efficiently.
The scientists screened around 30,000 molecules and found that a class of antibiotic molecules called pleicomacrolides had the ability to inhibit Nef. Pleicomacrolides are usually used in laboratories to destroy lysosome, which is the part of a cell that helps in the digestion of worn-out cell parts, viruses and bacteria. However, they are toxic in nature and thus are not used as drugs.
On further examination, the team of scientists found that concanamycin A, a type of pleicomacrolide, could restrict the activity of Nef at much lower concentrations than those used to inhibit lysosomes. This reduced the chances of short-term toxicity in the surrounding cells.
When the researchers used concanamycin A to treat HIV-infected Nef-expressing cells, they found that it activated the cytotoxic T cells (a type of immune cells), which then cleared off the infected cells.
Scientists believe that while it seems a little risky right now, this research has the potential to become rewarding in future. However, more research needs to be done on this drug before it could be used for the treatment of those who have HIV.
For more information, read our article on HIV/AIDS.
Health articles in Firstpost are written by myUpchar.com, India’s first and biggest resource for verified medical information. At myUpchar, researchers and journalists work with doctors to bring you information on all things health.
The information provided here is intended to provide free education about certain medical conditions and certain possible treatment. It is not a substitute for examination, diagnosis, treatment, and medical care provided by a licensed and qualified health professional. If you believe you, your child or someone you know suffers from the conditions described herein, please see your health care provider immediately. Do not attempt to treat yourself, your child, or anyone else without proper medical supervision. You acknowledge and agree that neither myUpchar nor firstpost is liable for any loss or damage which may be incurred by you as a result of the information provided here, or as a result of any reliance placed by you on the completeness, accuracy or existence of any information provided herein.
By Herbert Lash and Tom Wilson NEW YORK/LONDON (Reuters) -The dollar rose and key U.S., European and global stock indexes hovered near record highs on Friday as investors embraced the easy monetary policies of major central banks and their message that rising inflation will be transitory.
By Laila Kearney NEW YORK (Reuters) -Oil prices reached fresh multi-year highs on Friday, heading for a third straight week of gains on an improved outlook for worldwide demand as rising vaccination rates lead to a lifting of pandemic curbs. Brent crude futures rose 30 cents to $72.82 a barrel by 1:34 p.m.
By Tom Arnold and Tom Wilson LONDON (Reuters) - El Salvador may be touting bitcoin's use to help its citizens living abroad send funds back home, but the biggest remittance firms are cautious about offering cryptocurrency services. In a move that could be a harbinger of crypto becoming a more popular way to send money across borders, El Salvador on Wednesday became the first country to adopt bitcoin as a parallel legal tender. President Nayib Bukele played up bitcoin's potential as a remittance currency for Salvadorans overseas